Table 4.

General characteristics of individual studies on prophylactic antifungal therapy as a part of a selective decontamination of the digestive tract regimen

Reference	Year	Country	Inclusion period	Study design
Unertl et al. [71]	1987	Germany	May 1984 to January 1985	RCT
Ledingham et al. [72]	1988	UK	July 1985 to November 1986	Cohort
Kerver et al. [73]	1988	The Netherlands	January 1985 to May 1986	RCT
Von Hünefeld [22]	1989	Germany	1987 to 1989	RCT
Ulrich et al. [74]	1989	The Netherlands	October 1986 to September 1987	RCT
McClelland et al. [75]	1990	UK	January 1987 to December 1987	Cohort
Hartenauer et al. [76]	1990	Germany	1989 to 1990	Non-random CT
Gaussorgues et al. [77]	1991	France	September 1988 to September 1991	RCT
Blair et al. [78]	1991	UK	September 1988 to January 1990	RCT
Aerdts et al. [79]	1991	The Netherlands	May 1985 to September 1987	RCT
Cerra et al. [80]	1992	USA	Not specified	RCT
Hammond et al. [81]	1992	South Africa	January 1989 to December 1990	RCT
Saunders et al. [82]	1994
Cockerill et al. [83]	1992	USA	1986 to 1989	RCT
Winter et al. [84]	1992	UK	22 months	RCT
Ferrer et al. [85]	1994	Spain	Not specified	RCT
Langlois-Karaga et al. [86]	1995	France	2 years	RCT
Luiten et al. [87]	1995	The Netherlands	April 1990 to April 1993	RCT
Wiener et al. [88]	1995	USA	8 months	RCT
Quinio et al. [89]	1996	France	Not specified	RCT
Verwaest et al. [90]	1997	Belgium	19 months	RCT
Abele-Horn et al. [91]	1997	Germany	Not specified	RCT
de La Cal et al. [92]	2005	Spain	May 1997 to January 2000	RCT

CT, controlled trial; RCT, randomised controlled trial.